A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/103.1
A61K 38/21 (2006.01)
Patent
CA 1291706
Abstract of the Disclosure Anti-tumor activity in humans can be augmented by administering to the human patient an effective amount of IFN-.beta. and IL-2 in combination. The composition of IFN-.beta. and IL-2 may be prepared in vitro or administered separately to the patient. The composition is useful for prophylactic or therapeutic treatment of such cancers as melanoma, colon cancer, lung cancer and breast cancer.
531905
Borden Ladner Gervais Llp
Cetus Corporation
Rudolph Alfred
LandOfFree
Combination therapy using interferon-.beta. and interleukin-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy using interferon-.beta. and interleukin-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy using interferon-.beta. and interleukin-2 will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1244222